| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.98B | +18.0% |
| R&D Expense | $3.11B | -1.7% |
| SG&A Expense | $3.64B | +35.7% |
| Operating Income | $2.80B | +152.2% |
| Interest Expense | $489.0M | -22.7% |
| Pre-tax Income | $4.13B | +77.7% |
| Income Tax | -$5.76B | -2803.3% |
| Net Income | $9.86B | +422.3% |
| EPS (Basic) | $4.71 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.89B | +25.9% |
| Short-term Investments | $1.08B | +49.1% |
| Accounts Receivable | $3.33B | -2.1% |
| Current Assets | $12.24B | +8.4% |
| Total Assets | $51.24B | +32.4% |
| Current Liabilities | $11.48B | +21.4% |
| Long-term Debt | $9.57B | +0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.14B | +99.1% |
| Capital Expenditures | $242.0M | +8.5% |
| Investing Cash Flow | -$3.18B | +1.5% |
| Financing Cash Flow | -$2.09B | -2096.8% |
| Free Cash Flow | $6.89B | +105.1% |
| +406.5% |
| EPS (Diluted) | $4.56 | +424.1% |
| Total Liabilities |
| $28.77B |
| +10.6% |
| Stockholders' Equity | $21.56B | +91.6% |